These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3794711)

  • 1. In situ molecular size of agonist dopamine D-2 binding sites in rat striatum.
    Gredal O; Nielsen M
    J Neurochem; 1987 Feb; 48(2):364-9. PubMed ID: 3794711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
    Gredal O; Nielsen M
    J Neurochem; 1987 Feb; 48(2):370-5. PubMed ID: 3491877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor binding in bovine intermediate lobe pituitary membranes.
    Sibley DR; Creese I
    Endocrinology; 1980 Nov; 107(5):1405-9. PubMed ID: 7428676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
    Fuxe K; Agnati LF; Köhler C; Kuonen D; Ogren SO; Andersson K; Hökfelt T
    J Neural Transm; 1981; 51(1-2):3-37. PubMed ID: 7264628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S; Adams L; Hyttel J; Creese I
    Eur J Pharmacol; 1981 Mar; 70(1):71-5. PubMed ID: 7215442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
    J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
    Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
    J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correspondency between different affinity states and target size of the bovine striatal D2 dopamine receptor.
    Kuno T; Tanaka C
    Biochem Biophys Res Commun; 1983 Nov; 117(1):65-70. PubMed ID: 6197972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites.
    Dubois A; Scatton B
    Neurosci Lett; 1985 Jun; 57(1):7-12. PubMed ID: 3162114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
    Zhang X; Segawa T
    Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X; Segawa T
    Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
    Korf J; Sebens JB; Flentge F; van der Werf JF
    J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct target size of dopamine D-1 and D-2 receptors in rat striatum.
    Nielsen M; Klimek V; Hyttel J
    Life Sci; 1984 Jul; 35(3):325-32. PubMed ID: 6235424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.